Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Biomaterials and Regenerative Medicine in Ophthalmology Dermatology - A Colour Guide 2nd Edition Ischaemic Heart Disease, 1st Revised Edition Intensive Review of Cardiology      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing a category Home  - Healthcare and Medical Devices     - Diagnostics       - You are in Rapid Cardiac Markers category    Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC   Sorted by Date Added U.S. Cardiac Biomarkers Diagnostics Markets Frost & Sullivan, Dec 2007, Pages: 61 This research service analyzes the market for cardiac biomarkers within the United States The United States market was divided into the acute myocardial infarction diagnostics and congestive heart fai... Successful Management of Heart Failure Patients: Multidisciplinary Approach to Reducing Readmissions Healthcare Intelligence Network, Oct 2007, Pages: 23 Approximately 5 million people in the United States have heart failure, with 550,000 new cases diagnosed annually The condition is the number one cause for hospitalization among the elderly; one fifth... 2004 U.S. Hospital Point-of-Care Cardiac Marker Survey Enterprise Analysis Corporation (EAC), Nov 2004, Pages: 76 Cardiac Marker POC testing has shown explosive growth in the hospital market sector. In 2001 Cardiac Marker POC instruments were being used in only 4% of U.S. hospitals, by 2004 this has grown to 12%.... Drugs of Tomorrow: Chronic and Acute Heart Failure- Diverse Strategies for a Complex Disease Datamonitor, Aug 2002 There is a need for new therapies for heart failure, as disease rates remain high. Current prevalence estimates for chronic heart failure range from 1-2% of the population, totaling over 13m patients ... Cardiac Markers - Making their Mark on the Medicines Market Datamonitor, Jan 2002 This brief sets out to: * Review the available diagnostic markers for cardiac ischemia, atherosclerotic disease, heart failure, and platelet No more results

		Top of page

All rights reserved. © Copyright 2009 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster